#ECR2015: Hologic Satellite Symposium: Screening with Breast Tomosynthesis: An Emerging Reality

The amount of clinical proof for the efficacy of Tomosynthesis in screening is significantly larger than the proof available in the early days of the transition from analog mammography to FFDM. 

Results from studies in Europe using Tomosynthesis in population based screening and results from screening with Tomosynthesis in the USA are concordant around an increase in invasive cancer detection and a reduction in recall rates. As screening programs begin the adoption of Tomosynthesis, many questions arise around the practical implementation of the technology; however, current literature is primarily focused around the clinical results. 

Presenters at the symposium will share their experiences with the challenges, the solutions and the early results from implementing Tomosynthesis in primary screening for breast cancer.

Friday, March 6th 
14:00 - 15.30 
Room C


Moderator of Session:

Prof. emer. Per Skaane

Speakers/Presentations:

  • Sarah M. Friedewald, MD. Chicago, USA

    The American experience

  • Dra. Marina Álvarez Benito / Dra. Sara Romero. Córdoba, España
    The Spanish experience

  • Dott.ssa Daniela Bernardi. Trento, Italia

    The Italian experience

  • Prof.emer. Per Skaane. Oslo, Norge

    The Norwegian experience 

Published on : Thu, 26 Feb 2015


Print as PDF

Screening, Breast, Tomosynthesis, Hologic, breast cancer screening, breast imaging, #ECR15 The amount of clinical proof for the efficacy of Tomosynthesis in screening issignificantly larger than the proof available in the early days of the transi

No comment


Please login to leave a comment...

Highlighted Products